[Form 4] Artivion, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jean F. Holloway, SVP & General Counsel of Artivion, Inc. (AORT), reported transactions on 08/25/2025. She exercised a stock option to acquire 10,000 shares at an exercise price of $11.03 per share and concurrently sold 10,000 shares at $44.37 per share. After these transactions she beneficially owned 172,129 shares. The option exercised relates to a grant with an $11.03 exercise price, originally exercisable beginning 11/08/2023 and expiring 11/08/2029; the option vests 33 1/3% per year starting on the first anniversary of the grant date.

Positive

• Exercise of options at $11.03 enabled acquisition at a low strike versus market sale price
• Retained significant ownership: 172,129 shares remain beneficially owned after transactions
• Clear option disclosure: exercisable since 11/08/2023 with expiration 11/08/2029 and stated vesting schedule

Negative

• Insider sale of 10,000 shares on 08/25/2025 could be viewed as reduction in holdings
• Large spread realized: sale price $44.37 versus exercise $11.03 highlights substantial insider monetization

Insights

Financial Analyst

TL;DR: Insider exercised options at $11.03 and sold at $44.37, realizing a material spread while retaining 172,129 shares.

The filing documents a routine option exercise and immediate sale by a senior executive. The exercise price of $11.03 versus sale price of $44.37 implies a substantial per-share gain on 10,000 shares. The reporting person retains a meaningful ownership stake of 172,129 shares, suggesting continued alignment with shareholders. Transaction timing appears administrative and consistent with option vesting; no new issuance or unusual derivative structures are reported.

Corporate Governance / Compliance Specialist

TL;DR: The Form 4 shows standard Section 16 reporting for an exercised and sold option; disclosure appears complete and timely.

The Form 4 identifies the reporting person, relationship to issuer, transaction dates, option terms and resulting beneficial ownership. The derivative table lists the option exercise details including exercisable and expiration dates and vesting schedule. The filing is signed and dated 08/26/2025, consistent with timely reporting obligations.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Holloway Jean F

(Last) (First) (Middle)

1655 ROBERTS BLVD., NW

(Street)

KENNESAW GA 30144

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		M		10,000	A	$11.03	182,129	D
Common Stock	08/25/2025		S		10,000	D	$44.37	172,129	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$11.03	08/25/2025		M			10,000	11/08/2023(1)	11/08/2029	Common Stock	10,000	$0	0	D

Explanation of Responses:

1. Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023.

Remarks:

	/s/ Jean F Holloway	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When did Jean F. Holloway report the transaction for AORT?

The transactions occurred on 08/25/2025 and the Form 4 is signed 08/26/2025.

How many shares did the reporting person acquire and sell?

Acquired 10,000 shares by exercising an option and sold 10,000 shares on the same date.

What was the exercise price and sale price reported on the Form 4?

Exercise price: $11.03 per share; Sale price: $44.37 per share.

How many AORT shares does Jean F. Holloway beneficially own after the transactions?

172,129 shares are reported as beneficially owned following the transactions.

What are the key terms of the stock option exercised?

Option to buy 10,000 shares with an $11.03 exercise price, exercisable from 11/08/2023, expiring 11/08/2029, vesting 33 1/3% per year from first anniversary.